BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38353902)

  • 1. Neuroimaging features of primary central nervous system post-transplantation lymphoproliferative disorder following hematopoietic stem cell transplant in patients with β-thalassemia: a case series and review of literature.
    Yang X; Deng X; Wu M; Chen SW; Jiang M; Long L; Chen BT
    Insights Imaging; 2024 Feb; 15(1):40. PubMed ID: 38353902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Susceptibility-weighted imaging and diffusion-weighted imaging findings in central nervous system monomorphic B cell post-transplant lymphoproliferative disorder before and after treatment and comparison with primary B cell central nervous system lymphoma.
    Ginat DT; Purakal A; Pytel P
    J Neurooncol; 2015 Nov; 125(2):297-305. PubMed ID: 26341369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary CNS post-transplant lymphoproliferative disorder following haploidentical HSCT using post-transplant high-dose cyclophosphamide.
    Toyosaki M; Onizuka M; Amaki J; Shiraiwa S; Aoyama Y; Machida S; Kawai H; Murayama H; Ogiya D; Matsui K; Kawakami S; Harada K; Kondo Y; Hirabayashi K; Nakamura N; Ogawa Y; Kawada H; Ando K
    Blood Cell Ther; 2019 Feb; 2(1):1-4. PubMed ID: 37969696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary central nervous system post-transplantation lymphoproliferative disorder: A case report and systematic review of imaging findings.
    Hoyt D; Hughes J; Liu J; Ayyad H
    Radiol Case Rep; 2024 Jun; 19(6):2168-2182. PubMed ID: 38515768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case series of primary central nervous system posttransplantation lymphoproliferative disorder: imaging and clinical characteristics.
    Lake W; Chang JE; Kennedy T; Morgan A; Salamat S; Başkaya MK
    Neurosurgery; 2013 Jun; 72(6):960-70; discussion 970. PubMed ID: 23685504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A disease warranting attention from neurosurgeons: primary central nervous system post-transplant lymphoproliferative disorder.
    Jin L; Lu D; Yan F; Han J; Wei P; Zhou Y; Wang Y; Shan Y; Zhao G
    Front Neurol; 2024; 15():1392691. PubMed ID: 38813246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary central nervous system post-transplantation lymphoproliferative disorder: an International Primary Central Nervous System Lymphoma Collaborative Group Report.
    Cavaliere R; Petroni G; Lopes MB; Schiff D;
    Cancer; 2010 Feb; 116(4):863-70. PubMed ID: 20052713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Central Nervous System Post-transplant Lymphoproliferative Disorder Misdiagnosed as Glioblastoma: A Case Report.
    Tanaka H; Matsuda R; Nakamura M; Nakagawa I; Nakase H
    Anticancer Res; 2022 Aug; 42(8):3975-3979. PubMed ID: 35896237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
    Zimmermann H; Nitsche M; Pott C; Reinke P; Babel N; Hermann RM; Hauser IA; Hahn D; Ritgen M; Pietschmann C; Klapper W; Anagnostopoulos I; Trappe RU;
    Ann Hematol; 2021 Aug; 100(8):2043-2050. PubMed ID: 33973053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of neoplastic post-transplant lymphoproliferative disorder following hematopoietic stem cell transplant in β-thalassemia: A pediatric case report.
    Zhang X; Hao W; Xu T; Liu S; Jiang H
    Medicine (Baltimore); 2017 Dec; 96(52):e9055. PubMed ID: 29384898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBV-positive post-transplant lymphoproliferative disorder presenting as primary diffuse large B-cell lymphoma of the central nervous system.
    Xu H; Rewerska J; Aardsma N; Slavin K; Valyi-Nagy T; Ni H
    Folia Neuropathol; 2017; 55(3):221-226. PubMed ID: 28984115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus-associated posttransplant lymphoproliferative disorder involving the central nervous system following autologous hematopoietic stem cell transplantation for neuroblastoma.
    Sano H; Fujimoto M; Okuno K; Ueyama J; Takano S; Hayashi K; Kanzaki S
    Springerplus; 2014; 3():582. PubMed ID: 25332882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Primary central nervous system post-transplant lymphoproliferative disorders].
    Honda M; Koga M; Kanda T
    Brain Nerve; 2014 Aug; 66(8):947-54. PubMed ID: 25082316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monomorphic Post-transplant Lymphoproliferative Disorder After Kidney Transplantation and Hematopoietic Stem Cell Transplantation: Clinicopathological Characteristics, Treatments and Prognostic Factors.
    Fu L; Xie J; Lin J; Wang J; Wei N; Huang D; Wang T; Shen J; Zhou X; Wang Z
    Indian J Hematol Blood Transfus; 2017 Dec; 33(4):492-499. PubMed ID: 29075059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary central nervous system post-transplant lymphoproliferative disorder after allogeneic stem cell transplantation: a case report.
    Tugend M; Dattero J; Shore T; Korobeynikov V; Sekula RF
    Front Oncol; 2024; 14():1284577. PubMed ID: 38313803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.
    Chen DB; Song QJ; Chen YX; Chen YH; Shen DH
    Int J Hematol; 2013 Jan; 97(1):117-24. PubMed ID: 23255160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Subacute cognitive impairment and urinary retention due to primary central nervous system post-transplant lymphoproliferative disorder: a case report].
    Yokoyama N; Kanbayashi T; Kobayashi S; Ishida T; Sonoo M
    Rinsho Shinkeigaku; 2021 Nov; 61(11):750-755. PubMed ID: 34657922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-transplant lymphoproliferative disorders after solid organ and hematopoietic stem cell transplantation.
    Romero S; Montoro J; Guinot M; Almenar L; Andreu R; Balaguer A; Beneyto I; Espí J; Gómez-Codina J; Iacoboni G; Jarque I; López-Andújar R; Mayordomo-Aranda E; Montalar J; Pastor A; Pastor M; Piñana JL; Rojas-Ferrer N; Sánchez-Lázaro I; Sandoval J; Sanz G; Sanz MÁ; Solé A; Sanz J
    Leuk Lymphoma; 2019 Jan; 60(1):142-150. PubMed ID: 29966464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.
    Yoon JH; Lee S; Kim HJ; Lee JW; Min WS; Chung BH; Yang CW; Kim YS; Kim JI; Moon IS; Oh EJ; Park GS; Cho SG
    Transpl Int; 2014 Jul; 27(7):721-32. PubMed ID: 24684689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.